icd 10 diagnosis code for urine drug screening

by Kiarra Emard Published 2 years ago Updated 1 year ago 10 min read

ICD-10-CM Codes that Support Medical Necessity

For monitoring of patient compliance in a drug treatment program, use diagnosis code Z03. 89 as the primary diagnosis and the specific drug dependence diagnosis as the secondary diagnosis.

What is the diagnosis code for urine drug screen?

2 rows · Feb 09, 2020 · Valid for Submission ICD-10: R82.5 Short Description: Elevated urine levels of ...

What is the ICD 10 diagnosis code for?

2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code. Applicable To. Elevated urine levels of catecholamines. Elevated urine levels of indoleacetic acid. Elevated urine levels of 17-ketosteroids. Elevated urine levels of steroids. ICD-10-CM Diagnosis Code Z13.89 [convert to ICD-9-CM] Encounter for screening for other disorder. , no symptoms; Loss of protective …

What does ICD 10 do you use for EKG screening?

Dec 08, 2021 · What is the ICD-10 code for drug screening? Z02. 83 – Encounter for Blood-alcohol and Blood-drug Test [Internet]. In: ICD-10-CM. What is the CPT code for drug screen urine? Overview and Clinical Utility: Urine drug screen (USDL) is a group test that is currently billed at the group test level of CPT code 81000.

What are the urine drug test codes?

Apr 26, 2022 · Long Description: Increased medication, medicament, and biological substance levels in the urine. Also, what is the drug screening ICD 10 code? Meeting for a blood alcohol and drug test. The ICD-10-CM code Z02. 83 is a billable/specific code that can be used to identify a diagnosis for reimbursement purposes. ICD-10-CM Z02 in its 2020 revision.

What ICD 10 codes cover urinalysis?

Unspecified abnormal findings in urine

R82. 90 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R82. 90 became effective on October 1, 2021.

What is Z02 89 diagnosis code?

Encounter for other administrative examinations

ICD-10 code Z02. 89 for Encounter for other administrative examinations is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .

What is CPT code for urine drug screen?

Overview and Clinical Utility:

Urine drug screen (USDL) is a group test that is currently billed at the group test level of CPT code 81000.Sep 24, 2009

What is the ICD 10 code for medical clearance for work?

1: Encounter for pre-employment examination.

What is diagnosis code Z51 81?

2022 ICD-10-CM Diagnosis Code Z51. 81: Encounter for therapeutic drug level monitoring.

What is procedure code 99080?

Code 99080 is for “Special reports such as insurance forms, more than the information conveyed in the usual medical communications or standard reporting form.” Medicare and many other payers consider payment for these reports to be bundled into the payment made for other services and will not separately reimburse it.

What is the difference between presumptive and definitive drug testing?

A: A presumptive test is one used to identify possible use or non-use of a drug or Drug Class. Presumptive tests are not definitive. They only screen for the presence of a compound. A definitive or confirmation test is one that uses instrument analysis to positively identify the presence or quantity of a drug.

What is presumptive drug testing?

‒ Presumptive drug testing is a screen that is often conducted with point-of-care. (POC) devices that are usually quick, qualitative, and inexpensive, but results. require confirmation.2. ‒ Definitive drug testing quantifies specific substances (ie, drugs, metabolites)

What is the code for a Drug test?

CPT code 80305: Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g. immunoassay) capable of being read by direct optical observation only (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service.May 7, 2020

Can Z02 89 be used as a primary diagnosis?

The code Z02. 89 describes a circumstance which influences the patient's health status but not a current illness or injury. The code is unacceptable as a principal diagnosis.

What is medical clearance?

The term is often used by surgeons requesting a medical evaluation before performing surgery on a patient. In the context of surgery, a medical clearance is, essentially, considered to be an authorization from an evaluating doctor that a patient is cleared, or deemed healthy enough, for a proposed surgery.

When performing diagnostic coding you use the?

Proper diagnosis coding involves using the ICD-10-CM volumes to select the appropriate codes for diseases, disorders, or other medical conditions affecting the patient based on documentation in his or her medical record and assigning those codes correctly on claims.

General Information

Article Guidance

This article contains coding that complements the Local Coverage Determination (LCD) for Urine Drug Testing.

Bill Type Codes

Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the article does not apply to that Bill Type.

Revenue Codes

Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other Revenue Codes are equally subject to this coverage determination.

Document Information

CMS National Coverage Policy

Title XVIII of the Social Security Act, §1862 (a) (1) (A). Allows coverage and payment for only those services that are considered to be reasonable and necessary.#N#Title XVIII of the Social Security Act, §1833 (e). Prohibits Medicare payment for any claim which lacks the necessary information to process the claim.#N#42 CFR 410.32 (a).

Coverage Guidance

Purpose#N#Urine drug testing (UDT) provides objective information to assist clinicians in identifying the presence or absence of drugs or drug classes in the body and making treatment decisions.#N#This policy details:#N#The appropriate indications and expected frequency of testing for safe medication management of prescribed substances in risk stratified pain management patients and/or in identifying and treating substance use disorders.#N#Designates documentation, by the clinician caring for the beneficiary in the beneficiary’s medical record, of medical necessity for, and testing ordered on an individual patient basis;#N#Provides an overview of presumptive urine drug testing (UDT) and definitive UDT testing by various methodologies.#N#This policy addresses UDT for Medicare patients only.#N#Definitions#N#As used in this document, the following terminology relates to the basic forms of UDT:#N#Presumptive/Qualitative Drug Testing (hereafter called "presumptive" UDT) - Used when medically necessary to determine the presence or absence of drugs or drug classes in a urine sample; results expressed as negative or positive or as a numerical result; includes competitive immunoassays (IA) and thin layer chromatography.#N#Definitive/Quantitative/Confirmation (hereafter called “definitive” UDT) - Used when medically necessary to identify specific medications, illicit substances and metabolites; reports the results of analytes absent or present typically in concentrations such as ng/ml; definitive methods include, but are not limited to GC-MS and LC-MS/MS testing methods only.#N#Specimen Validity Testing - Urine specimen testing to ensure that it is consistent with normal human urine and has not been adulterated or substituted, may include, but is not limited to pH, specific gravity, oxidants and creatinine.#N#Immunoassay (IA) - Ordered by clinicians primarily to identify the presence or absence of drug classes and some specific drugs; biochemical tests that measure the presence above a cutoff level of a substance (drug) with the use of an antibody; read by photometric technology.#N#Point of Care Testing (POCT) - Used when medically necessary by clinicians caring for the beneficiary for immediate test results for the immediate management of the beneficiary; available when the beneficiary and physician are in the same location; IA test method that primarily identifies drug classes and a few specific drugs; platform consists of cups, dipsticks, cassettes, or strips; read by the human eye, or read by instrument assisted direct optical observation.#N#Standing Orders - Test request for a specific patient representing repetitive testing to monitor a condition or disease for a limited number of sequential visits; individualized orders for certain patients for pre-determined tests based on historical use, risk and community trend patient profiles; clinician can alter the standing order.#N#Blanket Orders - Test request that is not for a specific patient; rather, it is an identical order for all patients in a clinician’s practice without individualized decision making at every visit.#N#Reflex Testing - Laboratory testing that is performed "reflexively" after initial test results to identify further diagnostic information essential to patient care.